1. Avian and Mammalian Facilitative Glucose Transporters
    Mary Shannon Byers et al, 2017, Microarrays CrossRef
  2. GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
    Young Wha Koh et al, 2017, J Pathol Transl Med CrossRef
  3. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway
    Umesh Mahajan et al, 2017, IJMS CrossRef
  4. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan et al, 2017, Cell Biosci CrossRef
  5. Plant Flavone Apigenin: an Emerging Anticancer Agent
    Eswar Shankar et al, 2017, Curr Pharmacol Rep CrossRef
  6. Regulation of hepatic hydroxy methyl glutarate – CoA reductase for controlling hypercholesterolemia in rats
    Abeer A. Khamis et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  7. Hypoxia promotes mitochondrial glutamine metabolism through HIF1α-GDH pathway in human lung cancer cells
    Zi-Feng Jiang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  8. Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism
    Zongdong Li et al, 2018, Biochem. J. CrossRef
  9. Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy.
    Angela R Guerra et al, 2018, J Agric Food Chem CrossRef
  10. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: a study based on immunohistochemistry and RNA sequencing data
    Young Wha Koh et al, 2019, Lung Cancer CrossRef
  11. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis
    Pyone Myat Thu et al, 2019, European Journal of Pharmacology CrossRef
  12. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma
    Manmohan S. Jangdey et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  13. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
    Tiago MA. Carvalho et al, 2019, European Journal of Medicinal Chemistry CrossRef
  14. From Krebs to clinic: glutamine metabolism to cancer therapy.
    Brian J Altman et al, 2016, Nat Rev Cancer CrossRef
  15. Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis
    Yoon-Mi Lee et al, 2019, IJMS CrossRef
  16. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth
    Elena S. Reckzeh et al, 2019, Cell Chemical Biology CrossRef
  17. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters
    Young Wha Koh et al, 2017, Lung Cancer CrossRef
  18. Apigenin: A current review on its beneficial biological activities
    Xiang Zhou et al, 2017, J Food Biochem CrossRef
  19. null
    Deborah L. Baines et al, 2017 CrossRef
  20. 18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer
    Honglian Liu et al, 2019, Breast Cancer CrossRef
  21. Apigenin as an anticancer agent.
    Muhammad Imran et al, 2020, Phytother Res CrossRef
  22. Apigenin attenuates Aluminum phosphide-induced cytotoxicity via reducing mitochondrial/Lysosomal damages and oxidative stress in rat Cardiomyocytes
    Asal Jahedsani et al, 2020, Pesticide Biochemistry and Physiology CrossRef
  23. Apigenin inhibits NF-κB and Snail signaling, EMT and metastasis in human hepatocellular carcinoma
    Yuan Qin et al, 2106, Oncotarget CrossRef
  24. Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
    Xiao-Yu Ai et al, 2017, Oncotarget CrossRef
  25. Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells
    Lian Chen et al, 2016, Oncotarget CrossRef
  26. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
    Fatemeh Abbaszadeh et al, 2020, Pharmacological Research CrossRef
  27. Glutaminases regulate glutathione and oxidative stress in cancer
    José M. Matés et al, 2020, Arch Toxicol CrossRef
  28. The phenolic profile and biological activities of the wild-edible mushrooms Helvella leucopus and Morchella pulchella
    İsmail Acar et al, 2020, Food Measure CrossRef
  29. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review
    Aldo Pezzuto et al, 2020, Thorac Cancer CrossRef
  30. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
    Milad Ashrafizadeh et al, 2020, Front. Chem. CrossRef
  31. Power of two: Combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
    Kalpana Tilekar et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  32. null
    Prasanta Dey et al, 2021 CrossRef
  33. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy
    The Hong Phong Nguyen et al, 2021, Process Biochemistry CrossRef
  34. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
    José M. Matés et al, 2020, CMC CrossRef
  35. Amino Acid Depletion Therapies: Starving Cancer Cells to Death
    Miriam Butler et al, 2021, Trends in Endocrinology & Metabolism CrossRef
  36. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment
    Zeeshan Javed et al, 2021, Cancer Cell Int CrossRef
  37. Integrative Treatment of Lung Cancer Patients: Observational Study of 57 Cases
    Lorenzo Anelli et al, 2021, Asian Journal of Oncology CrossRef
  38. Apigenin Improves Hypertension and Cardiac Hypertrophy Through Modulating NADPH Oxidase-Dependent ROS Generation and Cytokines in Hypothalamic Paraventricular Nucleus
    Hong-Li Gao et al, 2021, Cardiovasc Toxicol CrossRef
  39. Phytocompounds Targeting Metabolic Reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance
    Asifa Khan et al, 2021, J. Agric. Food Chem. CrossRef
  40. null
    Ana Carolina Silveira Rabelo, 2021 CrossRef
  41. Pharmacologic approaches to amino acid depletion for cancer therapy
    Carly S. Wilder et al, 2021, Molecular Carcinogenesis CrossRef
  42. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  43. Reactive oxygen species: Key players in the anticancer effects of apigenin?
    Omolola R. Oyenihi et al, 2022, Journal of Food Biochemistry CrossRef
  44. A Comprehensive and Current Review on the Role of Flavonoids in Lung Cancer: Experimental and Theoretical Approaches
    Şeyda Berk et al, 2022, Phytomedicine CrossRef
  45. Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cells
    Aljohra M. Al-Otaibi et al, 2022, Environ Sci Pollut Res CrossRef
  46. Insulin and cancer: a tangled web
    Brooks P. Leitner et al, 2022 CrossRef
  47. null
    Deepti Singh et al, 2022 CrossRef
  48. Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent
    Yun Zhou et al, 2022, Food and Chemical Toxicology CrossRef
  49. Recent updates on anticancer mechanisms of polyphenols
    Eshita Sharma et al, 2022, Front. Cell Dev. Biol. CrossRef
  50. Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
    Masoud Moslehi et al, 2022, Clin Exp Pharma Physio CrossRef
  51. Glutamine metabolism in cancers: Targeting the oxidative homeostasis
    Tengfang Gong et al, 2022, Front. Oncol. CrossRef
  52. Chemotherapeutic Role of Polyphenols Present in Ocimum sanctum
    Saima Khatoon et al, 2022, ACAMC CrossRef
  53. Green synthesized apigenin conjugated gold nanoparticles inhibit cholangiocarcinoma cell activity and endothelial cell angiogenesis in vitro
    Nipaporn Ngernyuang et al, 2022, Heliyon CrossRef
  54. null
    Tanja Lunić et al, 2023 CrossRef
  55. Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer
    Sunil Kumar et al, 2023, Phytomedicine Plus CrossRef
  56. Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells
    Maryam Ghanbari-Movahed et al, 2023, Metabolites CrossRef
  57. Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
    Martina Spada et al, 2023, Antioxidants CrossRef
  58. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening
    Jiaqian Zhao et al, 2023, Journal of Pharmaceutical Analysis CrossRef
  59. Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy
    Priya Shetti et al, 2023, Top Catal CrossRef
  60. Himalayan flora: targeting various molecular pathways in lung cancer
    Abija James et al, 2023, Med Oncol CrossRef
  61. Integrated network pharmacology and cellular assay reveal the biological mechanisms of Limonium sinense (Girard) Kuntze against Breast cancer
    Hualong Zhao et al, 2023, BMC Complement Med Ther CrossRef
  62. An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention
    Rebecca Mary Peter et al, 2023, Pharm Res CrossRef